Yury Popov

7.2k total citations · 1 hit paper
71 papers, 4.8k citations indexed

About

Yury Popov is a scholar working on Hepatology, Epidemiology and Molecular Biology. According to data from OpenAlex, Yury Popov has authored 71 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Hepatology, 29 papers in Epidemiology and 19 papers in Molecular Biology. Recurrent topics in Yury Popov's work include Liver physiology and pathology (29 papers), Liver Disease Diagnosis and Treatment (28 papers) and Pediatric Hepatobiliary Diseases and Treatments (10 papers). Yury Popov is often cited by papers focused on Liver physiology and pathology (29 papers), Liver Disease Diagnosis and Treatment (28 papers) and Pediatric Hepatobiliary Diseases and Treatments (10 papers). Yury Popov collaborates with scholars based in United States, Germany and China. Yury Popov's co-authors include Detlef Schuppan, Deanna Sverdlov, Eleonora Patsenker, Detlef Schuppan, Detlef Schuppan, Susan B. Liu, Kahini A. Vaid, Naoki Ikenaga, Zhenwei Peng and Felix Stickel and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Yury Popov

71 papers receiving 4.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hepatocyte mitochondria-derived danger signals directly activate hepatic stellate cells and drive progression of liver fibrosis

2020 228 citations Ping An, Linlin Wei et al. Nature Communications profile →

Peers

Countries citing papers authored by Yury Popov

Since Specialization

Citations

This map shows the geographic impact of Yury Popov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yury Popov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yury Popov more than expected).

Fields of papers citing papers by Yury Popov

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yury Popov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yury Popov. The network helps show where Yury Popov may publish in the future.

Co-authorship network of co-authors of Yury Popov

This figure shows the co-authorship network connecting the top 25 collaborators of Yury Popov. A scholar is included among the top collaborators of Yury Popov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yury Popov. Yury Popov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Single-cell atlas of human liver and blood immune cells across fatty liver disease stages reveals distinct signatures linked to liver dysfunction and fibrogenesis 2025 ·Nature Immunology ·(unknown), (unknown), (unknown), (unknown), (unknown), Lai Ping Wong, Pinzhu Huang, (unknown), Charlotte Costentin, Shadi Salloum, (unknown), (unknown), (unknown), Stuti G. Shroff, Kathleen E. Corey, Yury Popov, Edgar D. Charles, Ruslan I. Sadreyev, Raymond T. Chung, Nadia Alatrakchi	2
2	Metabolomic Hallmarks of Obesity and Metabolic Dysfunction-Associated Steatotic Liver Disease 2024 ·International Journal of Molecular Sciences ·Diren Beyoğlu, Yury Popov, Jeffrey R. Idle	12
3	Transposon-based oncogene integration in Abcb4(Mdr2)-/- mice recapitulates high susceptibility to cholangiocarcinoma in primary sclerosing cholangitis 2024 ·Journal of Hepatology ·Pinzhu Huang, Guangyan Wei, Jesse D. Kirkpatrick, (unknown), Li Tan, (unknown), Imad Nasser, (unknown), (unknown), (unknown), (unknown), Wen Gao, Kahini A. Vaid, Shuangshuang Zhao, (unknown), (unknown), Xin Chen, Gregory J. Gores, Yury Popov	3
4	The Metabolomic Footprint of Liver Fibrosis 2024 ·Cells ·Diren Beyoğlu, Yury Popov, Jeffrey R. Idle	3
5	ASK1/p38 axis inhibition blocks the release of mitochondrial “danger signals” from hepatocytes and suppresses progression to cirrhosis and liver cancer 2024 ·Hepatology ·Zhenwei Peng, Guangyan Wei, Pinzhu Huang, (unknown), Wen Gao, Ping An, Shuangshuang Zhao, (unknown), Li Tan, Kahini A. Vaid, (unknown), Imad Nasser, Grant R. Budas, David López, Li Li, David G. Breckenridge, Rob Myers, John G. McHutchison, Ming Kuang, Yury Popov	7
6	Metabolic Hijacking of Hexose Metabolism to Ascorbate Synthesis Is the Unifying Biochemical Basis of Murine Liver Fibrosis 2023 ·Cells ·Diren Beyoğlu, Pinzhu Huang, (unknown), (unknown), Yury Popov, Jeffrey R. Idle	5
7	Single Ionization of Helium by Protons of Various Energies in the Parabolic Quasi-Sturmians Approach 2023 ·Atoms ·S. A. Zaytsev, (unknown), (unknown), L. U. Ancarani, О. Чулуунбаатар, Konstantin Kouzakov, Yury Popov	2
8	Hepatocyte mitochondria-derived danger signals directly activate hepatic stellate cells and drive progression of liver fibrosis breakdown → 2020 ·Nature Communications ·Ping An, Linlin Wei, Shuangshuang Zhao, Deanna Sverdlov, Kahini A. Vaid, Makoto Miyamoto, Kaori Kuramitsu, Michelle Lai, Yury Popov	228
9	Lysyl Oxidase (LOX) Family Members: Rationale and Their Potential as Therapeutic Targets for Liver Fibrosis 2020 ·Hepatology ·Wei Chen, Aiting Yang, Jidong Jia, Yury Popov, Detlef Schuppan, Hong You	181
10	Synthetic human ABCB4 mRNA therapy rescues severe liver disease phenotype in a BALB/c.Abcb4 mouse model of PFIC3 2020 ·Journal of Hepatology ·Guangyan Wei, Jingsong Cao, Pinzhu Huang, Ping An, (unknown), Kahini A. Vaid, Shuangshuang Zhao, David Q.‐H. Wang, (unknown), Ling Yin, Andrea Frassetto, (unknown), Vladimir Presnyak, Srujan Gandham, Serenus Hua, Christine Lukacs, Patrick F. Finn, Paloma H. Giangrande, Paolo G.V. Martini, Yury Popov	48
11	A novel non‐bile acid FXR agonist EDP‐305 potently suppresses liver injury and fibrosis without worsening of ductular reaction 2020 ·Liver International ·Ping An, Guangyan Wei, Pinzhu Huang, Wenda Li, Xiaolong Qi, (unknown), Kahini A. Vaid, Jun Wang, Shucha Zhang, Yang Li, Yat Sun Or, Lijuan Jiang, Yury Popov	45
12	3D analysis of microvasculature in murine liver fibrosis models using synchrotron radiation-based microtomography 2020 ·Angiogenesis ·Willi L. Wagner, (unknown), (unknown), Yong Oock Kim, Yury Popov, Detlef Schuppan, Katja Schladitz, Claudia Redenbach, Maximilian Ackermann	7
13	Comparison of murine steatohepatitis models identifies a dietary intervention with robust fibrosis, ductular reaction, and rapid progression to cirrhosis and cancer 2019 ·American Journal of Physiology-Gastrointestinal and Liver Physiology ·Guangyan Wei, Ping An, Kahini A. Vaid, Imad Nasser, Pinzhu Huang, Li Tan, Shuangshuang Zhao, Detlef Schuppan, Yury Popov	57
14	Distinct roles of ecto-nucleoside triphosphate diphosphohydrolase-2 (NTPDase2) in liver regeneration and fibrosis 2017 ·Purinergic Signalling ·Linda Feldbrügge, Z. Gordon Jiang, Eva Csizmadia, Shuji Mitsuhashi, Stephanie Tran, Eric U. Yee, Sonja Rothweiler, Kahini A. Vaid, Jean Sévigny, Moritz Schmelzle, Yury Popov, Simon C. Robson	19
15	The ectonucleotidase ENTPD1/CD39 limits biliary injury and fibrosis in mouse models of sclerosing cholangitis 2017 ·Hepatology Communications ·Zhenwei Peng, Sonja Rothweiler, Guangyan Wei, Naoki Ikenaga, Susan B. Liu, Deanna Sverdlov, Kahini A. Vaid, Maria Serena Longhi, Ming Kuang, Simon C. Robson, Yury Popov	29
16	Selective targeting of lysyl oxidase-like 2 (LOXL2) suppresses hepatic fibrosis progression and accelerates its reversal 2017 ·Gut ·Naoki Ikenaga, Zhenwei Peng, Kahini A. Vaid, Susan B. Liu, Shuhei Yoshida, Deanna Sverdlov, Amanda Mikels‐Vigdal, Victoria Smith, Detlef Schuppan, Yury Popov	219
17	Mass-encoded synthetic biomarkers for multiplexed urinary monitoring of disease 2011 ·DSpace@MIT (Massachusetts Institute of Technology) ·Geoffrey von Maltzahn, Gayathree Murugappan, Steven Mo, Deanna Sverdlov, Susan B. Liu, Yury Popov, Detlef Schuppan, Gabriel A. Kwong, Andrew Warren, Ioannis A. Papayannopoulos, (unknown), (unknown), Sangeeta N. Bhatia	151
18	Macrophage-mediated phagocytosis of apoptotic cholangiocytes contributes to reversal of experimental biliary fibrosis 2010 ·American Journal of Physiology-Gastrointestinal and Liver Physiology ·Yury Popov, Deanna Sverdlov, K. Ramakrishnan Bhaskar, (unknown), Gunda Millonig, Eleonora Patsenker, Stephan Krähenbühl, L. Krähenbühl, Detlef Schuppan	111
19	GUT-DERIVED BACTERIAL PRODUCTS DRIVE PROGRESSION OF LIVER FIBROSIS IN MDR2-/- MICE: INVOLVEMENT OF LPS AND TLR4 2009 ·Data Archiving and Networked Services (DANS) ·Klaas Poelstra, Yury Popov, Deanna Sverdlov, (unknown), Detlef Schuppan	1
20	Role of the receptor for advanced glycation end products inhepatic fbrosis 2009 ·World Journal of Gastroenterology ·(unknown), Daniel Neureiter, Yury Popov, Michael Bauer, Detlef Schuppan	42

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact